GlassScriptPhysician profile
Daniel Davidson Oxley
NPI 1174572796
$8,632.31
in general payments reported to CMS, 2019-2025
16 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.23 · 2021: $7,576 · 2022: $124 · 2023: $90.47 · 2024: $318 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,626.56 | 2021-2023 | Da Vinci Surgical System |
| Stryker Corporation | $351.85 | 2022-2025 | Actishield Cf, Aequalis Ascend Flex, Flowtriever Catheter, S |
| Medtronic, INC. | $219.49 | 2025 | Ligasure |
| Lexington Medical, INC. | $73.84 | 2021 | |
| Boston Scientific Corporation | $69.99 | 2025 | Enroute Transcarotid Stent, Varithena Administration Pack |
| Davol INC. | $64.91 | 2025 | Bard 3dmax Mesh |
| Innovation Technologies INC | $64.46 | 2025 | Irrisept |
| Bard Peripheral Vascular, INC. | $28.06 | 2022 | |
| Hologic Sales and Service, LLC | $25.09 | 2024 | Trunode |
| Neuros Medical, INC. | $18.24 | 2025 | Altius |
| Solventum Corporation | $16.69 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Avanos Medical | $16.63 | 2019 | |
| Silk Road Medical, INC. | $16.26 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Smith+Nephew, INC. | $15.64 | 2023 | Collagenase Santyl |
| Bolder Surgical LLC | $13.03 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Oxley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.